$22M is nothing if you don't spend it correctly, a lot of biotech start-up I've invest in have done CR for $20M and managed to use it for 3-4 years but mind you they don't have expenditure of $6-8M per quarter which has only happened when AHZ was "trying" to get ADAPT to the market, hopefully with this "transformational" change, management can control their expenditure to $4M.
do not advertise external links.au/...ocel-and-vascucel-for-362-million-904705.html
- Forums
- ASX - By Stock
- Ann: CardioCel and VascuCel rights sold to LeMaitre Vascular
$22M is nothing if you don't spend it correctly, a lot of...
-
- There are more pages in this discussion • 178 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M |
Open | High | Low | Value | Volume |
$15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 297 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 1300 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 14.800 |
1 | 206 | 14.500 |
1 | 1388 | 14.400 |
1 | 60 | 14.350 |
1 | 38 | 14.260 |
Price($) | Vol. | No. |
---|---|---|
15.250 | 1300 | 2 |
15.400 | 238 | 1 |
15.500 | 370 | 1 |
15.660 | 1925 | 2 |
15.950 | 848 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
AVR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online